See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Social Media
Eid
Artificial Intelligence
Tariffs
Donald Trump
Taxes
European Union
Stock Markets
Baseball
Senate
Education
Published • loading... • Updated

AIM Vaccine submits mRNA RSV vaccine for FDA clinical trials

Summary by News Medical
AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to the U.S. Food and Drug Administration (FDA).

2 Articles

All
Left
Center
1
Right
News MedicalNews Medical
Center

AIM Vaccine submits mRNA RSV vaccine for FDA clinical trials

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to the U.S. Food and Drug Administration (FDA).

·United States
Read Full Article
Johns Hopkins UniversityJohns Hopkins University

The Long History of mRNA Vaccines | Johns Hopkins Bloomberg School of Public Health

A look at how this vaccine technology has been in the works for decades.

·Baltimore, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Johns Hopkins University broke the news in Baltimore, United States on Monday, February 10, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Vaccines

Vaccines

San Diego

San Diego

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal